Takeda Cuts Profit Forecast on Shire Deal, Lifts Revenue Outlook

(Bloomberg) -- Takeda Pharmaceutical Co. lowered its annual operating profit forecast by 24 percent to include the impact of its $62 billion acquisition of Shire Plc, while at the same time raising...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.